322 related articles for article (PubMed ID: 22411462)
1. Role of IL28B polymorphism in the development of hepatitis C virus-induced hepatocellular carcinoma, graft fibrosis, and posttransplant antiviral therapy.
Eurich D; Boas-Knoop S; Bahra M; Neuhaus R; Somasundaram R; Neuhaus P; Neumann U; Seehofer D
Transplantation; 2012 Mar; 93(6):644-9. PubMed ID: 22411462
[TBL] [Abstract][Full Text] [Related]
2. IL-28B rs12979860 polymorphism affect the course of chronic hepatitis and the development of HCC in Egyptian patients with hepatitis C type 4.
Attallah AM; Omran D; Marie MS; Abdelrazek M; Salama A; El Essawey R; Mobarak L; Maklad S; Omar A
Br J Biomed Sci; 2018 Oct; 75(4):157-162. PubMed ID: 29914308
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism in interferon L3 is an independent risk factor for development of hepatocellular carcinoma after treatment of hepatitis C virus infection.
Chang KC; Tseng PL; Wu YY; Hung HC; Huang CM; Lu SN; Wang JH; Lee CM; Chen CH; Tsai MC; Yen YH; Lin MT; Wu CK; Huang CC; Chen HH; Hu TH
Clin Gastroenterol Hepatol; 2015 May; 13(5):1017-24. PubMed ID: 25460552
[TBL] [Abstract][Full Text] [Related]
4. Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation.
Eurich D; Boas-Knoop S; Ruehl M; Schulz M; Carrillo ED; Berg T; Neuhaus R; Neuhaus P; Neumann UP; Bahra M
Liver Transpl; 2011 Mar; 17(3):289-98. PubMed ID: 21384511
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Uridine⁻Cytidine Kinase Like-1 Protein and IL28B rs12979860 and rs8099917 SNPs on the Development of Hepatocellular Carcinoma in Cirrhotic Chronic Hepatitis C Patients-A Pilot Study.
Buivydiene A; Liakina V; Kashuba E; Norkuniene J; Jokubauskiene S; Gineikiene E; Valantinas J
Medicina (Kaunas); 2018 Sep; 54(5):. PubMed ID: 30344298
[No Abstract] [Full Text] [Related]
6. CC genotype at rs12979860 of IL28B is associated with lower risk of new-onset diabetes after transplantation in adult patients with liver transplantation for hepatitis C cirrhosis.
Duca AM; de la Fuente S; Citores MJ; Cuenca AB; Cisneros E; Escamilla N; Baños I; Vilches C; Cuervas-Mons V
Transplant Proc; 2014 Nov; 46(9):3114-6. PubMed ID: 25420838
[TBL] [Abstract][Full Text] [Related]
7. Association of mannose-binding lectin-2 gene polymorphism with the development of hepatitis C-induced hepatocellular carcinoma.
Eurich D; Boas-Knoop S; Morawietz L; Neuhaus R; Somasundaram R; Ruehl M; Neumann UP; Neuhaus P; Bahra M; Seehofer D
Liver Int; 2011 Aug; 31(7):1006-12. PubMed ID: 21733090
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-28B TT genotype is frequently found in patients with hepatitis C virus cirrhosis but does not influence hepatocarcinogenesis.
de la Fuente S; Citores MJ; Duca A; Cisneros E; Baños I; Vilches C; Cuervas-Mons V
Clin Exp Med; 2017 May; 17(2):217-223. PubMed ID: 27083168
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of severe hepatitis C virus recurrence after liver transplantation in patients with a T allele of IL28B rs12979860.
Cisneros E; Baños I; Citores MJ; Duca A; Salas C; Noblejas A; Cañizares M; Millán I; Cuervas-Mons V; Vilches C
Transplantation; 2012 Aug; 94(3):275-80. PubMed ID: 22790387
[TBL] [Abstract][Full Text] [Related]
10. Utility of the low-accelerating-dose regimen in 182 liver recipients with recurrent hepatitis C virus.
Lim KB; Sima HR; Fiel MI; Khaitova V; Doucette JT; Chernyiak M; Ahmad J; Bach N; Chang C; Grewal P; Kim-Schluger L; Liu L; Odin J; Perumalswami P; Florman SS; Schiano TD
World J Gastroenterol; 2015 May; 21(20):6236-45. PubMed ID: 26034358
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin 28B gene polymorphism in Turkish patients with hepatocellular carcinoma.
Akkiz H; Kuran S; Akgöllü E; Usküdar O; Bekar A; Bayram S
Ann Hepatol; 2014; 13(6):788-95. PubMed ID: 25332265
[TBL] [Abstract][Full Text] [Related]
12. The course of posttransplant hepatitis C infection: comparative impact of donor and recipient source of the favorable IL28B genotype and other variables.
Duarte-Rojo A; Veldt BJ; Goldstein DD; Tillman HL; Watt KD; Heimbach JK; McHutchison JG; Poterucha JJ; Vargas-Vorackova F; Charlton MR
Transplantation; 2012 Jul; 94(2):197-203. PubMed ID: 22766768
[TBL] [Abstract][Full Text] [Related]
13. Impact of EGF, IL28B, and PNPLA3 polymorphisms on the outcome of allograft hepatitis C: a multicenter study.
Mueller JL; King LY; Johnson KB; Gao T; Nephew LD; Kothari D; Simpson MA; Zheng H; Wei L; Corey KE; Misdraji J; Lee JH; Lin MV; Gogela NA; Fuchs BC; Tanabe KK; Gordon FD; Curry MP; Chung RT
Clin Transplant; 2016 Apr; 30(4):452-60. PubMed ID: 26854475
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C without sustained response to combination therapy.
Chang KC; Ye YH; Wu CK; Lin MT; Tsai MC; Tseng PL; Hu TH
J Formos Med Assoc; 2018 Nov; 117(11):1011-1018. PubMed ID: 29254684
[TBL] [Abstract][Full Text] [Related]
15. IL28B rs12979860 gene polymorphism in Egyptian patients with chronic liver disease infected with HCV.
Zekri AR; Salama H; Medhat E; Bahnassy AA; Morsy HM; Lotfy MM; Ahmed R; Darwish T; Marei MS
Asian Pac J Cancer Prev; 2014; 15(17):7213-8. PubMed ID: 25227816
[TBL] [Abstract][Full Text] [Related]
16. The association of IL28B polymorphism and graft survival in patients with hepatitis C undergoing liver transplantation.
Allam SR; Krüger B; Mehrotra A; Schiano T; Schröppel B; Murphy B
PLoS One; 2013; 8(1):e54854. PubMed ID: 23382988
[TBL] [Abstract][Full Text] [Related]
17. The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection: An updated meta-analysis.
Qin S; Wang J; Zhou C; Xu Y; Zhang Y; Wang X; Wang S
Medicine (Baltimore); 2019 Sep; 98(38):e17275. PubMed ID: 31568008
[TBL] [Abstract][Full Text] [Related]
18. Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection.
Lange CM; Moradpour D; Doehring A; Lehr HA; Müllhaupt B; Bibert S; Bochud PY; Antonino AT; Pascual M; Farnik H; Shi Y; Bechstein WO; Moench C; Hansmann ML; Sarrazin C; Lötsch J; Zeuzem S; Hofmann WP
J Hepatol; 2011 Aug; 55(2):322-7. PubMed ID: 21147186
[TBL] [Abstract][Full Text] [Related]
19. YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Eurich D; Neumann UP; Boas-Knoop S; Neuhaus R; Kiessling A; Yahyazadeh A; Trautwein C; Wasmuth H; Puhl G; Neuhaus P; Bahra M
J Gastroenterol Hepatol; 2013 Jan; 28(1):153-60. PubMed ID: 22989351
[TBL] [Abstract][Full Text] [Related]
20. HCV-related liver and lymphoproliferative diseases: association with polymorphisms of IL28B and TLR2.
De Re V; De Zorzi M; Caggiari L; Lauletta G; Tornesello ML; Fognani E; Miorin M; Racanelli V; Quartuccio L; Gragnani L; Russi S; Pavone F; Ghersetti M; Costa EG; Casarin P; Bomben R; Mazzaro C; Basaglia G; Berretta M; Vaccher E; Izzo F; Buonaguro FM; De Vita S; Zignego AL; De Paoli P; Dolcetti R
Oncotarget; 2016 Jun; 7(25):37487-37497. PubMed ID: 27183918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
